GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Advicenne SA (XPAR:ALDVI) » Definitions » Float Percentage Of Total Shares Outstanding

Advicenne (XPAR:ALDVI) Float Percentage Of Total Shares Outstanding : 0.00% (As of May. 31, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Advicenne Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Advicenne's float shares is 0.00 Mil. Advicenne's total shares outstanding is 12.28 Mil. Advicenne's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Advicenne's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Advicenne's Institutional Ownership is 1.60%.


Advicenne Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Advicenne's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/12.28
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Advicenne (XPAR:ALDVI) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Advicenne SA (XPAR:ALDVI) » Definitions » Float Percentage Of Total Shares Outstanding
Traded in Other Exchanges
Address
2, rue Briconnet, Nimes, FRA, F-30 000
Advicenne SA is a late-stage biopharmaceutical company. The company is engaged in the development of paediatric friendly therapeutics for the treatment of orphan renal diseases and niche neurology indications. Its goal is to improve the lives of patients from early childhood through adulthood.

Advicenne (XPAR:ALDVI) Headlines

No Headlines